Bio-Path Holdings

-$0.06 (-1.85%) Today
$0.00 (0.00%) As of 8:00 PM UTC after-hours

Why Robinhood?

You can watch BPTH and buy or sell other stocks, options, and ETFs commission-free!

About BPTH

Bio-Path Holdings, Inc. is a biotechnology company, which engages in the development of therapies for acute myeloid leukemia (AML) and chronic myeloid leukemia (CML). Its product pipeline includes Prexigebersen, BP1002, and BP1003.

CEO
Peter H. Nielsen
Employees
10
Headquarters
Bellaire, Texas
Founded
2007

BPTH Key Statistics

Market cap
22.77M
Price-Earnings ratio
—
Dividend yield
—
Average volume
33.18K
High today
—
Low today
—
Open price
—
Volume
0.00
52 Week high
$8.62
52 Week low
$2.68
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure